<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="403">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 24, 2013</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01038583</url>
  </required_header>
  <id_info>
    <org_study_id>1U01AG029824-01A2</org_study_id>
    <nct_id>NCT01038583</nct_id>
  </id_info>
  <brief_title>Aspirin in Reducing Events in the Elderly</brief_title>
  <acronym>ASPREE</acronym>
  <official_title>Aspirin in Reducing Events in the Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minneapolis Medical Research Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Health and Medical Research Council, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Monash University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Berman Center for Outcomes and Clinical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Minneapolis Medical Research Foundation</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ASPREE study will examine whether the potential benefits of low dose aspirin
      (particularly preventing heart disease, stroke, certain cancers and dementia) outweigh the
      risks (particularly bleeding) in people over age 65.

      ASPREE will determine whether taking a daily low-dose aspirin will extend the length of a
      disability-free life in healthy participants aged 65 years and above.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Low dose aspirin therapy has been shown to reduce the risk of vascular events, largely in
      middle-aged people.  There is also some evidence of its potential to reduce the rate of
      intellectual decline and certain types cancers in older participants.  However, part of the
      benefit of aspirin may be offset by adverse effects, such as those related to its potential
      to cause bleeding.

      The balance of risks and benefits of low dose aspirin has not been established in older
      persons.  Previous studies on the effects of aspirin in primary prevention have mainly
      focused on cardiovascular outcomes. In the elderly, these alone may not be the most
      appropriate measure of benefit associated with aspirin treatment. Prolonging a life free of
      functional disability in a healthy aging population would be the most desirable benefit of
      aspirin as a preventative medicine.

      ASPREE will determine whether taking a daily low-dose aspirin will extend the length of a
      disability-free life in healthy participants aged 65 years and above.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>The primary endpoint is death from any cause or incident, dementia or persistent physical disability.</measure>
    <time_frame>every 6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>every 6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatal and non fatal cardiovascular events including a) coronary heart disease death, b) non-fatal MI, c) fatal and non-fatal stroke and d) any hospitalization for heart failure</measure>
    <time_frame>every 6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatal and non-fatal cancer, excluding non-melanoma skin cancer</measure>
    <time_frame>every 6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dementia</measure>
    <time_frame>every 6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mild Cognitive Impairment (MCI; assessed using the Modified Mini-Mental State Examination or 3MS 70 and other cognitive function measures - see below)</measure>
    <time_frame>every 6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical disability</measure>
    <time_frame>every 6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major hemorrhagic events</measure>
    <time_frame>every 6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">19000</enrollment>
  <condition>Functional Disability</condition>
  <condition>Dementia</condition>
  <condition>Heart Disease</condition>
  <condition>Stroke</condition>
  <condition>Cancer</condition>
  <condition>Bleeding</condition>
  <arm_group>
    <arm_group_label>Aspirin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>100 mg enteric-coated aspirin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>100 mg enteric-coated aspirin</intervention_name>
    <description>100 mg enteric-coated aspirin, taken daily</description>
    <arm_group_label>Aspirin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>100 mg enteric-coated placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women

          -  African American and Hispanic persons age 65 or older

          -  Any person from another ethnic minority group age 70 or older

          -  Willing and able to provide informed consent, and willing to accept the study
             requirements

        [ASPREE has completed enrollment of Caucasian participants in the US.]

        Exclusion Criteria:

          -  A history of a diagnosed cardiovascular event

          -  A serious intercurrent illness likely to cause death within the next 5 years, such as
             terminal cancer or obstructive airways disease

          -  A current or recurrent condition with a high risk of major bleeding, ex: cerebral
             aneurysm

          -  Anemia

          -  Absolute contraindication or allergy to aspirin

          -  Current participation in a clinical trial

          -  Current continuous use of aspirin or other anti-platelet drug or anticoagulant for
             secondary prevention.  People with previous use of aspirin for primary prevention may
             enter the trial, provided they agree to cease existing use of aspirin and understand
             that they may be subsequently randomly allocated to low dose aspirin or placebo.

          -  A systolic blood pressure ≥180 mmHg and / or a diastolic blood pressure ≥105 mmHg

          -  A history of dementia

          -  Severe difficulty or an inability to perform any one of the 6 Katz ADLs

          -  Non-compliance to taking pill
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Grimm, MD, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Berman Center for Outcomes and Clinical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John McNeil, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Monash University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nathan J Tessum</last_name>
    <phone>612-341-7907</phone>
    <email>ntessum@bermancenter.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Brenda Kirpach</last_name>
    <phone>612-341-7922</phone>
    <email>bkirpach@bermancenter.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cathy Stallings</last_name>
      <phone>205-934-7683</phone>
    </contact>
    <investigator>
      <last_name>Beth Lewis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Palo Alto Medical Foundation Research Institute</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elsie Wang</last_name>
      <phone>650-853-2871</phone>
    </contact>
    <investigator>
      <last_name>Latha Palaniappan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Howard University</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oludolapo Ogunlana</last_name>
      <phone>202-865-1973</phone>
    </contact>
    <investigator>
      <last_name>Thomas Obisesan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida Department of Aging and Geriatrics</name>
      <address>
        <city>Gainsville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Chappelle</last_name>
      <phone>352-273-5919</phone>
    </contact>
    <investigator>
      <last_name>Steven Anton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory/ Atlanta VAMC</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Stennett</last_name>
      <phone>404-321-6111</phone>
      <phone_ext>7364</phone_ext>
    </contact>
    <investigator>
      <last_name>Peter Wilson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Morehouse School of Medicine</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30310</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Connie Jones</last_name>
      <phone>404-752-1133</phone>
    </contact>
    <investigator>
      <last_name>Pricilla Pema, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Georgia Health Sciences University</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Darlene Gibson</last_name>
      <phone>706-721-4335</phone>
      <email>dagibson@gru.edu</email>
    </contact>
    <investigator>
      <last_name>Daron Ferris, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush Alzheimer's Disease Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Graham</last_name>
      <phone>312-942-6118</phone>
    </contact>
    <investigator>
      <last_name>Raj Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Ernst</last_name>
      <phone>319-384-7756</phone>
    </contact>
    <investigator>
      <last_name>Michael Ernst, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kansas University Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalya Stolyar</last_name>
      <phone>913-945-7676</phone>
    </contact>
    <investigator>
      <last_name>Jeffery Burns, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pennington Biomedical Research Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidi Millet</last_name>
      <phone>225-763-3089</phone>
    </contact>
    <investigator>
      <last_name>Timothy Church, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mary Bird Perkins Our Lady of the Lake Cancer Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70809</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dawn Rachal</last_name>
      <phone>225-215-1185</phone>
      <email>drachal@marybird.com</email>
    </contact>
    <investigator>
      <last_name>David Hanson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baton Rouge General</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidi Millet</last_name>
      <phone>225-763-3089</phone>
      <email>Heidi.Millet@pbrc.edu</email>
    </contact>
    <investigator>
      <last_name>Timothy Church, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mary Bird Perkins St. Tammany Parish Hospital</name>
      <address>
        <city>Covington</city>
        <state>Louisiana</state>
        <zip>70433</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Nunez</last_name>
      <email>jnunez@marybird.com</email>
    </contact>
    <investigator>
      <last_name>Patricia Braly, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mary Bird Perkins Terrebonne General Hospital</name>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <zip>70360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Toups</last_name>
      <email>Ann.toups@tgmc.com</email>
    </contact>
    <investigator>
      <last_name>Raul Doria, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LSU Health Sciences- New Orleans</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renee Jenkins</last_name>
      <phone>504-568-2108</phone>
      <email>rjenk4@lsuhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Augusto Ochoa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tulane Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandria Augustus</last_name>
      <phone>504-988-6124</phone>
      <email>aaugustu@tulane.edu</email>
    </contact>
    <investigator>
      <last_name>William Robinson III, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LSU Health Sciences- Shreveport</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori Panu</last_name>
      <phone>318-813-1405</phone>
      <email>lpanu@lsuhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Gary Burton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denise Cornish</last_name>
      <phone>734-998-7947</phone>
    </contact>
    <investigator>
      <last_name>Jocelyn Wiggins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Wayne State University</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisabeta Levcovici</last_name>
      <phone>313-993-0419</phone>
    </contact>
    <investigator>
      <last_name>John Flack, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Detroit Clinical Research Center</name>
      <address>
        <city>Novi</city>
        <state>Michigan</state>
        <zip>48377</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonia Amin</last_name>
      <phone>248-773-8979</phone>
    </contact>
    <investigator>
      <last_name>Mutahhar Ahmad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Health Partners Research Foundation</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Pritchard</last_name>
      <phone>612-341-1957</phone>
    </contact>
    <investigator>
      <last_name>Karen Margolis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Phalen Village Clinic</name>
      <address>
        <city>St. Paul</city>
        <state>Minnesota</state>
        <zip>55106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lea Seaquist</last_name>
      <phone>651-793-8640</phone>
    </contact>
    <investigator>
      <last_name>Kevin Peterson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Jersey Medical Center</name>
      <address>
        <city>Elizabeth</city>
        <state>New Jersey</state>
        <zip>07202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Namrata Thakkar</last_name>
      <phone>908-576-8038</phone>
    </contact>
    <investigator>
      <last_name>Mandeep Oberoi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New Jersey Medical College</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yasmeen Beckett</last_name>
      <phone>973-972-3173</phone>
      <email>barberys@umdnj.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Wieder, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SUNY Downstate Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikita Watson</last_name>
      <phone>718-270-2931</phone>
      <email>nikita.watson@downstate.edu</email>
    </contact>
    <investigator>
      <last_name>Karen Benker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Winthrop University Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Migdalia Reid</last_name>
      <phone>516-663-2592</phone>
    </contact>
    <investigator>
      <last_name>John Aloia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queens Cancer Medical Center</name>
      <address>
        <city>Queens</city>
        <state>New York</state>
        <zip>11432</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Bulone, RN</last_name>
      <phone>718-883-3751</phone>
      <email>bulonel@nychhc.org</email>
    </contact>
    <investigator>
      <last_name>Parampreet Bakshi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Baptist Medical Center</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27408</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Wittmer</last_name>
      <phone>336-713-8243</phone>
    </contact>
    <investigator>
      <last_name>Jamehl Demons, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Brody School of Medicine at ECU</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brittany Brown</last_name>
      <phone>252-744-1904</phone>
    </contact>
    <investigator>
      <last_name>James Powell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albert Einstein Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Whinner</last_name>
      <phone>215-456-1959</phone>
    </contact>
    <investigator>
      <last_name>Gregg Pressman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Health Sciences Research Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl Albig</last_name>
      <phone>412-383-1470</phone>
    </contact>
    <investigator>
      <last_name>Anne Newman, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Hospital of Rhode Island</name>
      <address>
        <city>Pawtucket</city>
        <state>Rhode Island</state>
        <zip>02860</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liz Coccio</last_name>
      <phone>401-729-2183</phone>
    </contact>
    <investigator>
      <last_name>Charles Eaton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Tennessee Health Science Center</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Caulfield</last_name>
      <phone>901-448-6732</phone>
    </contact>
    <investigator>
      <last_name>Suzanne Satterfield, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Meharry Medical College</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>57208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Skupien</last_name>
      <phone>615-327-5725</phone>
      <email>dskupien@mmc.edu</email>
    </contact>
    <investigator>
      <last_name>John Murray, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center at Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pat Knowles</last_name>
      <phone>214-648-3612</phone>
    </contact>
    <investigator>
      <last_name>Shawna Nesbitt, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of TX Medical Branch</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roxana Hirst</last_name>
      <phone>409-266-9641</phone>
    </contact>
    <investigator>
      <last_name>Elena Volpi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regional Academic Health Center</name>
      <address>
        <city>Harlingen</city>
        <state>Texas</state>
        <zip>78550</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Zuniga</last_name>
      <phone>956-365-8688</phone>
      <email>zunigaj3@uthscsa.edu</email>
    </contact>
    <investigator>
      <last_name>Sarah Espinoza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Health Science Center at San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Navarro</last_name>
      <phone>210-450-0550</phone>
    </contact>
    <investigator>
      <last_name>Sarah Espinoza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.aspree.org</url>
  </link>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 18, 2013</lastchanged_date>
  <firstreceived_date>December 21, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aspirin</keyword>
  <keyword>Prevention</keyword>
  <keyword>Healthy</keyword>
  <keyword>Over 65 years old</keyword>
  <keyword>ASPREE</keyword>
  <keyword>Aspirin in Reducing Events in the Elderly</keyword>
  <keyword>Australia</keyword>
  <keyword>Functional disability</keyword>
  <keyword>Dementia</keyword>
  <keyword>Heart Disease/ Stroke</keyword>
  <keyword>Cancer</keyword>
  <keyword>Bleeding</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
